From: Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770
Randomization
ARV 53%
Combination 47%
Sex
F 55%
M = 45%
Age Range
18–62
Region
Urban 70%
Rural 30%
T
0 = 14%
1 = 86%
I
0 = 45%
1 = 55%
S
0 = 56%
1 = 44%